The Market for Minimally Invasive Medical Devices
The global market for MIS devices and equipment sales should grow from $21.2 billion in 2019 to $29.9 billion by 2024 with a compound annual growth rate (CAGR) of 7.1% for the period of 2019-2024.
- 38 tables
- An overview of the global markets for minimally invasive medical devices
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Regional dynamics of the market covering Americas, EMRA, APAC and other emerging economies
- Discussion of current state of minimally invasive surgical devices and equipments, commercialized and pipeline products, regulations and legislations, as well as key industry aspects
- Examination of vendor landscape and profiles of industry leading players, including B. Braun Aesculap, Fujifim Holdings Corp., Medtronic Ent Inc., Stryker Corp., Olympus Optical Co., Ltd. and Gyrus Acmi Corp.
This report is an analytical business tool whose primary purpose is to describe the minimally invasive surgical devices industry and the U.S. market for these devices. The scope of the study does not include:
- Devices and instruments used exclusively for traditional open surgical procedures (e.g., heart-lung machines).
- Devices and equipment used exclusively in an ambulatory surgery setting.
- Equipment for nonsurgical types of therapy such as radiation therapy.
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
The global market for MIS devices and equipment was about $14.5 billion in 2013. This market reached about $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a compound annual growth rate (CAGR) of 6.8% for the period 2014-2019.
- An overview of the global markets for minimally invasive medical devices and instruments.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Historical and current volume and value data for shipments, specified by end user and geographic markets.
- Evaluation of demographic, economic, and other factors that will drive future demand for minimally invasive devices.
- Details concerning promising new surgical procedures and products still in the development and testing stage, and assessments of the probability that they will be commercialized successfully in the next five years.
- Analysis of the potential market for these developmental procedures and products, taking into account the estimated probability that they will be commercialized.
- A look at the structure of the minimally invasive surgical devices industry (e.g., market shares, concentration, and recent M&A activity).
The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010. The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.
- The global market for MIS devices and instruments was worth $14.8 billion in 2008. This should reach $15.8 billion in 2009 and $23.0 billion in 2014, for a compound annual growth rate (CAGR) of 7.8%.
- The U.S. has the largest share of the market, worth $8.9 billion in 2008 and an estimated $9.5 billion in 2009. This segment is expected to reach $13.6 billion in 2014.
- Cardiothoracic surgery was the largest application segment for MIS devices and equipment in 2007, representing 70% of the total market. Cardiothoracic surgery was followed in order of size by orthopedic surgery (12%), gastrointestinal surgery (10%) and gynecology (3%).
The global market for minimally invasive surgery (MIS) devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011, an average annual growth rate (AAGR) of 7.5% between 2006 and 2011. (These figures include catheters, balloons, stents and other devices used in minimally invasive angioplasty.)
The U.S. accounted for about 60% of the world market, or $7.2 billion in 2005, and is growing at an AAGR of 7.2%. The U.S. market should reach $7.7 billion in 2006 and $11.0 billion by 2011.
Surgical devices (e.g, stents, catheters, guidewires) are the largest product segment of the U.S. minimally invasive surgery market, of which they accounted for about a 69% share in 2005. Monitoring and visualization systems were the second largest segment of the U.S. market in 2005, with an 11% market share, followed by endosurgical instruments (10%), electrosurgical equipment (8%), and robotics (2%). Surgical robots are the fastest-growing equipment /device segment, with an AAGR of 12% between 2006 and 2011, followed by surgical devices, with an AAGR of 8%.
Globally, the MIS devices market saw an average annual growth rate (AAGR) of 10% from 1999 to 2002.
By 2007, the market should rise to approximately $8.3 billion at an AAGR of 6.6%.
The U.S. market represents nearly 60% of the total world market.
Market drivers include demographics, epidemiology, new devices.
The lack of surgeons opting to train in MIS is a potential constraint on the market.